Report #2862521

Received Oct 1, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: Sep 18, 2025
Onset: Sep 18, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Expired product administered

Symptom narrative

received an expired dose of Arexvy vaccine last Thursday; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 20-AUG-2025) for prophylaxis. On 18-SEP-2025, the patient received Arexvy. On 18-SEP-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: received an expired dose of Arexvy vaccine last Thursday). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 23-SEP-2025 A nurse reported that a patient received an expired dose of Arexvy vaccine. The nurse asked if the patient should be revaccinated.